October 06, 2016
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Lindsay S. Lally, MD
Jessica K. Gordon, MD
Annel Fernandez
Emily Bakaj
Alexandra Morquette
The purpose of this registry is to identify factors that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of this study will provide vasculitis researchers insight into the causes of these diseases and generate new ideas of diagnostic test and therapies. Currently, we have 27 patients enrolled. Participation in this study involves a single 45 minute visit where clinical data will be collected as well as a blood draw.
Inclusion criteria:
Exclusion criteria: